Business
Schrodinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25
Schrodinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February
About this update from Schrodinger, Inc.
NEW YORK - Schrodinger, Inc. (Nasdaq: SDGR) will report its fourth quarter and full-year 2025 financial results on Wednesday, February 25, 2026 , after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET . The live webcast can be accessed in the 'Investors' section of Schrodinger's website and will be archived for approximately 90 days following the event. About Schrodinger Schrodinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrodinger's software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrodinger also leverages the platform to advance a portfolio of collaborative and internal programs. Founded in 1990, Schrodinger has approximately 800 employees operating from 15 locations globally. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com. Contact: Matthew Luchini (Investors) Schrodinger Inc. [email protected] 917-719-0636 Allie Nicodemo (Media) Schrodinger Inc. [email protected] 617-356-2325 (C) 2026 Electronic News Publishing, source ENP Newswire
More from Schrodinger, Inc.
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advan...
September 9, 2026
Schrodinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agent...
August 6, 2026